ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

Lion (4912): 2Q results: Growth in value-added and mix improvement above expectations

Published: 2026-08-07Institution: JPMorganPages: 9Original language: English

Research evidence excerpt

J P M O R G A N

Asia Pacific Equity Research

08 August 2026

Lion (4912)

2Q results: Growth in value-added and mix

improvement above expectations

Somewhat positive: 2Q core operating profit of ¥9.3 billion was ¥800 million

above our ¥8.5 billion estimate. Lion made better progress than expected in raising

value-add and in improving the sales mix. Accelerating oral healthcare sales

growth (+4.1% YoY in 1Q, +10.5% in 1H) and an upturn in sales in China (–26%

in 1Q, +14.3% in 2Q) were also positive. Management expects raw material costs

to worsen because of the deteriorating situation in the Middle East, but left full-year

earnings guidance unchanged. We feel the visibility of FY2027 earnings growth

has also improved.

Overweight

4912.T, 4912 JP

Price (07 Aug 26):¥1,798

Price Target (Dec-26):¥2,150

Japan Equity Research

Cosmetics and Personal Care /

Paper and Packaging

Akiko Kuwahara AC

(81-3) 6736-8617

JPMorgan Securities Japan Co., Ltd.

Summary of company briefing on key points: (1) Steps to absorb worsening

raw material costs caused by the deteriorating Middle East situation: Lion’s 2H

raw material cost estimate has worsened by ¥5 billion from initial guidance,

breaking down as ¥3 billion in 3Q and ¥2 billion in 4Q. To absorb this, Lion

aims to boost gross profit by ¥4 billion (+¥1 billion from cost-cutting, +¥3

billion from price hikes) and to improve SG&A expenses by ¥1 billion as well.

It expects boosts from price hikes of ¥500 million in 3Q and ¥2.5 billion in 4Q.

(2) Impact of changed assumptions for 2H guidance on FY2027: Lion expects

raw material costs to worsen by a further ¥5 billion in 1H FY2027, as well, and

will need factors adding ¥10 billion to profit to achieve its medium-term core

operating profit target (¥40 billion in FY2027). 4Q FY2026 price hikes will

contribute over the full year, as well as a further ¥4–5 billion uplift to profits

from a better sales mix. It will also implement cost controls. (3) Background

to forecast for ¥200 million YoY decline in 2H impact from changes in sales

volumes: On top of the specialty chemicals business and the REED brand

divestments, the company expects sales volume declines due to product price

hikes.…

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer